English
Insider transactions
EDGARPolaryx Therapeutics, Inc.
Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.
A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.
Window: transactions dated on or after 2025-11-20.
- Open-market purchases (code P)
- 2 transactions, 91,320 shares
- Sum of shares × price per share: 367,994.3257
- Open-market sales (code S)
- 0 transactions, — shares
Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.
Showing 1–2 of 2
| Date | Reporting owner | Code | Acquired or disposed | Shares | Price per share, as filed | Value (derived) | Shares owned after | Direct or indirect | Rule 10b5-1 box | Notes | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-27 Filed 2026-05-28 | Yang Alex Keun Mo Director · Officer: Chief Executive Officer · 10% ownerMstone Partners Healthcare Ltd Director · 10% owner | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 88,453 | 4.07 | 360,003.71Derived: shares × price per share. Exact value 360003.71. | 24,233,249 | Indirect (I) By Mstone Partners Healthcare Limited | No | F1, F2
| Open filing 0001213900-26-062322 Read from the filing’s XML Dispute this row |
| 2026-02-18 Filed 2026-02-20 | Landis G. Michael Director · Officer: Chief Financial Officer | POpen market or private purchase of non-derivative or derivative security | Acquired (A) | 2,867 | 2.7871 | 7,990.6157Derived: shares × price per share. Exact value 7990.6157. | 228,225 | Direct (D) | No | — | Open filing 0001213900-26-018845 Read from the filing’s XML Dispute this row |
Institutional holders (Form 13F)
Quarter ending 2026-09-30: 8,925 filings read, the latest filed 2026-11-19. Prior quarter ending 2026-06-30: 9,176 filings read.
Showing 1–13 of 13
| Manager | Shares or principal | Value as filed | Change from the prior quarter | Source |
|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 1,655,833 SH | 3,427,574 dollars | Lower by 2,039 Prior quarter: 1,657,872 | Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row |
| GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager | 138,757 SH | 287,406 dollars | Lower by 32,241 Prior quarter: 170,998 | Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row |
| VANGUARD FIDUCIARY TRUST CO | 80,320 SH | 166,262 dollars | Lower by 24,752 Prior quarter: 105,072 | Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row |
| STATE STREET CORP Partly reported under another manager | 68,004 SH | 140,768 dollars | Higher by 9,900 Prior quarter: 58,104 | Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row |
| BlackRock, Inc. Partly reported under another manager | 41,012 SH | 84,895 dollars | Unchanged Prior quarter: 41,012 | Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row |
| HRT FINANCIAL LP | 33,103 SH | 68 dollars | Lower by 48,991 Prior quarter: 82,094 | Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row |
| NORTHERN TRUST CORP Partly reported under another manager | 27,987 SH | 57,933 dollars | Unchanged Prior quarter: 27,987 | Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row |
| Cerity Partners LLC | 10,427 SH | 21,584 dollars | Not in the prior quarter’s filings read | Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row |
| Allworth Financial LP | 7,727 SH | 15,995 dollars | Unchanged Prior quarter: 7,727 | Open filing 0001140361-26-044466 Filed 2026-11-17 Dispute this row |
| Vanguard Global Advisers, LLC | 6,318 SH | 13,078 dollars | Unchanged Prior quarter: 6,318 | Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row |
| UBS Group AG Partly reported under another manager | 4,355 SH | 9,015 dollars | Higher by 3,072 Prior quarter: 1,283 | Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row |
| Tower Research Capital LLC (TRC) Partly reported under another manager | 1,855 SH | 3,840 dollars | Lower by 1,147 Prior quarter: 3,002 | Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row |
| BARCLAYS PLC Partly reported under another manager | 9 SH | 19 dollars | Not in the prior quarter’s filings read | Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row |
Managers in the prior quarter with no filing read for the latest
They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.
- JANE STREET GROUP, LLC 31,441 SH
- Fortitude Family Office, LLC 189 SH
- Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
- Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
- A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
- A change is the difference between two quarter-end snapshots, not a trade.
- A position reported under another manager may also appear in that manager’s filing; rows are not added together.
- Holdings the securities list cannot place with this company, or places ambiguously, are not shown.
Trades by members of Congress
Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.
No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.
5% holders (Schedule 13D and 13G)
Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.
| Holder | Percent of class | Shares held | Event date | Form | Source |
|---|---|---|---|---|---|
| Mstone Partners Healthcare Limited Common stock, par value $0.0001 per share ("Common Stock") | 47.4 | 22,452,954.00 | 01/29/2026 Filed 2026-02-05 | SCHEDULE 13D | Open filing 0001213900-26-012759 Dispute this row |
| MBstone Biotech Flagship Limited Common stock, par value $0.0001 per share ("Common Stock") | 0.4 | 183,560.00 | 01/29/2026 Filed 2026-02-05 | SCHEDULE 13D | Open filing 0001213900-26-012759 Dispute this row |
| Mstone Pediaorphan Singapore I Pte. Limited Common stock, par value $0.0001 per share ("Common Stock") | 0.2 | 108,282.00 | 01/29/2026 Filed 2026-02-05 | SCHEDULE 13D | Open filing 0001213900-26-012759 Dispute this row |
| Alex Keun Mo Yang Common stock, par value $0.0001 per share ("Common Stock") | 48.0 | 22,744,796.00 | 01/29/2026 Filed 2026-02-05 | SCHEDULE 13D | Open filing 0001213900-26-012759 Dispute this row |
Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.
What was read
2,592,621 filings read, dated 2004-06-14 to 2026-11-19: Forms 3, 3/A, 4, 4/A, 5, 5/A.
Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.
| Filing year | Filings read |
|---|---|
| 2015 | 17,857 |
| 2016 | 222,642 |
| 2017 | 222,009 |
| 2018 | 223,345 |
| 2019 | 216,482 |
| 2020 | 218,850 |
| 2021 | 249,835 |
| 2022 | 231,682 |
| 2023 | 229,674 |
| 2024 | 234,045 |
| 2025 | 235,520 |
| 2026 | 262,467 |
Filings made before the SEC required XML are listed, not extracted.